ArticlePatient preference and adherence2017

New insights into frequency and contents of fear of cancer progression/recurrence (FOP/FCR) in outpatients with colorectal carcinoma (CRC) receiving oral capecitabine: a pilot study at a comprehensive cancer center.

Jochen Hefner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.